Vaccine taskforce chief may benefit from £49m UK investment

Kate Bingham could profit from a taxpayer-backed stake in her private equity firm. Kate Bingham, chair of the government’s vaccine taskforce, is facing questions over whether she will benefit from a $65m (£49m) UK taxpayer-backed investment into a fund run by her private equity firm. Bingham, a venture capitalist married to Treasury minister Jesse Norman, has already come under fire over allegations she revealed sensitive information to a private investors’ conference and insisted on hiring costly PR advisers.